BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 1, 2003
View Archived Issues
Novel therapeutic strategies for diabetes
Read More
Janssen describes novel inhibitors of TNF-alpha and/or IL-12 production
Read More
Arpida prepares and tests novel antibacterial agents
Read More
Aventis presents new MCH receptor modulators with anorectic activity
Read More
Dual NK1 antagonists/5-HT reuptake inhibitors and their use reported by GSK
Read More
New glucokinase activators in early development at AstraZeneca
Read More
Oxytocin agonists with utility in erectile dysfunction claimed by Ferring
Read More
GSK scientists identify new Lp-PLA2 inhibitors for use in atherosclerosis therapy
Read More
Novel DNA protein kinase inhibitors discovered by Cancer Research Technology
Read More
New beta3-adrenoceptor agonists discovered at Lilly
Read More
Zonagen terminates Lavipharm merger agreement
Read More
Xenogen and Morphochem to develop novel compounds against bacterial biofilms
Read More
DOV Pharmaceutical reports on past four months
Read More
Hexvix improves treatment of bladder cancer patients
Read More
E.U. Erbitux filing remains on track following data review
Read More
FDA advisory committee sets May date for review of Xolair BLA
Read More
IL-10 gene therapy prolongs islet graft survival and inhibits diabetes recurrence in mice
Read More
Bay-41-2272 as an alternative to nitrate therapy for CHF and related disorders
Read More
CVT-4325, a new FOX inhibitor, induces a metabolic shift to glucose utilization in rat hearts
Read More
Selective inhibitor of Itk designed at BMS as lead compound for T-cell-mediated disorders
Read More
New series with strong activity against PTP1B presented at ACS meeting
Read More
Nonimidazole H3 receptor antagonist A-320436 characterized in preclinical experiments
Read More
Regeneron and Novartis to codevelop IL-1 Trap for RA
Read More
Johnson & Johnson completes acquisition of 3-DP
Read More
Normalization of lipid profiles in hypercholesterolemic rabbits on JTT-705
Read More
Chronic YM-598 restores myocardial energy metabolism to normal in CHF rats
Read More